Inhibitory effect of bufalin on retinoblastoma cells (HXO-RB44) via the independent mitochondrial and death receptor pathway.

Qingfeng Meng, Yan Zhao, LiXin An, Xia Li, Ping Liu

Open access · greenAbstract read

In one paragraph

Article in American journal of translational research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact, top 81% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini.Chinese journal of integrative medicine · 2024
Review
Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental Evaluation.Frontiers in pharmacology · 2020
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Qingfeng MengDepartment of Ophthalmology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, China.

Yan ZhaoDepartment of Allergy, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, China.

LiXin AnDepartment of Allergy, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, China.

Xia LiDepartment of Bioinformatic, The Harbin Medical University Harbin 150086, Heilongjiang Province, China.

Ping LiuDepartment of Ophthalmology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, China.

Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cinobufacini (Huachansu) is a Chinese medicine prepared from the skin of

Indexed as

Apoptosisbufalinmitochondrial transmembrane potentialretinoblastoma

Identifiers

PMID27904697

PMCPMC5126339

OpenAlexW3020966784

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.